A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure

Lancet Respir Med. 2023 Sep;11(9):759-760. doi: 10.1016/S2213-2600(23)00218-7. Epub 2023 Jun 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19* / complications
  • Humans
  • Hypoxia / etiology
  • Respiratory Insufficiency* / etiology
  • Respiratory Insufficiency* / therapy
  • Vasoactive Intestinal Peptide

Substances

  • Vasoactive Intestinal Peptide